Skin Microbiome, Inflammation, and Skin Toxicities in Women with Breast Cancer Receiving Moderately Hypofractionated Radiation Therapy
Jinbing Bai,
No information about this author
Claire Gong,
No information about this author
Yi‐Juan Hu
No information about this author
et al.
International Journal of Radiation Oncology*Biology*Physics,
Journal Year:
2025,
Volume and Issue:
unknown
Published: March 1, 2025
Language: Английский
Molecular profiling of skin cells identifies distinct cellular signatures in radiation-induced skin injury across various stages in the murine dataset
Hongxuan Yu,
No information about this author
Zhong Tao,
No information about this author
Ying Xu
No information about this author
et al.
Experimental Hematology and Oncology,
Journal Year:
2025,
Volume and Issue:
14(1)
Published: Feb. 25, 2025
Abstract
Background
Radiation-induced
skin
injury
(RISI)
commonly
manifests
in
cancer
patients
undergoing
radiotherapy
(RT).
However,
a
universally
accepted
standard
for
treating
radiation
has
not
yet
been
established.
Our
objective
was
to
provide
detailed
molecular
overview
of
pre-
and
post-radiation
therapy,
aiming
enhance
our
understanding
the
subclusters
mechanisms
contributing
radiodermatitis.
Methods
C57BL/6
mice
were
subjected
single
fraction
(20
Gy)
RT
targeting
right
dorsal
skin.
We
then
employed
integrated
single-cell
RNA
sequencing
(scRNA-seq)
analyze
samples
from
at
7
30
days
after
exposure,
as
well
non-irradiated
mice.
The
Seurat
analysis
pipeline,
Cellchat,
SCP,
ssGSEA
used
define
cell
types
involved
radiation-induced
injury.
Reverse
transcription
polymerase
chain
reaction
(RT-PCR),
multiplex
immunofluorescent
staining,
other
datasets
(GSE130183,
GSE193564,
GSE193807)
validate
findings.
Results
Thirty-two
distinct
clusters
encompassing
71,412
cells
identified.
discovered
that
cycling
keratinocytes
(KCs),
with
BMP
signaling
pathway
enriched,
could
activate
Wnt
pathway,
SMAD
pathways,
driving
wound
healing
fibrosis
processes
RISI.
Terminally
differentiated
secretory-papillary
fibroblasts
(Fibs)
are
capable
attracting
immune
cells,
which
contributes
pathogenesis
Lymphatic
endothelial
(ECs)
pro-inflammatory
properties
play
critical
role
RISI
by
facilitating
leukocyte
migration.
also
highlighted
enhanced
ligand-receptor
interactions,
notably
interactions
between
chemokines
like
CXCL10,
CCL2,
ACKR1,
across
inflammatory
KCs,
Fibs,
ECs,
underscoring
their
pivotal
recruitment
Conclusions
Cycling
lymphatic
ECs
roles
progression.
Targeting
these
might
help
improve
severity
Furthermore,
study
provides
valuable
resource
among
context
Graphical
Language: Английский
New trends in supportive care of head and neck cancers
Ilaria Mascagni,
No information about this author
Paolo Bossi
No information about this author
Current Opinion in Oncology,
Journal Year:
2025,
Volume and Issue:
unknown
Published: Feb. 24, 2025
Purpose
of
review
Supportive
care
plays
a
vital
role
in
the
management
head
and
neck
cancer
(HNC)
patients,
as
disease
often
affects
frail
older
population
that
is
treated
with
multiple
strategies
associated
severe
symptoms.
We
will
focus
on
mucositis,
dermatitis,
dysphagia,
pain,
cachexia,
infections,
they
are
among
most
common
challenging
symptoms
encountered.
Recent
findings
Efforts
have
focused
multiomics
approaches
to
decipher
complex
biological
pathways
drive
symptom
onset
treatment-related
toxicities,
aim
developing
novel
therapeutic
strategies.
A
notable
example
ponsegromab,
monoclonal
antibody
designed
target
cachexia.
Other
promising
areas
research,
such
machine-learning
models
oral
gut
microbiota
cachexia
actively
being
explored;
however,
their
impact
date
remains
limited.
Summary
In
recent
years,
new
knowledge
has
emerged
regarding
underlying
causes
predictive
for
supportive
HNC
patients.
Unfortunately,
this
expanding
body
primarily
adds
complexity
without
translating
into
practical
applications
or
substantial
improvements
Future
efforts
should
prioritize
standardization
algorithms,
generation
robust
evidence
based
existing
preclinical
models.
Language: Английский
Effect of an herbal gel for the prevention of radiation dermatitis-related symptoms: an open-label randomized clinical trial
Simeng Ren,
No information about this author
Jiayue Jin,
No information about this author
Xianrui Wu
No information about this author
et al.
Journal of Dermatological Treatment,
Journal Year:
2025,
Volume and Issue:
36(1)
Published: April 14, 2025
Radiation-induced
dermatitis
(RID)
is
the
most
frequent
side
effect
of
radiotherapy;
however,
no
effective
treatments
are
currently
available.
This
study
investigated
efficacy
and
safety
an
herbal
gel
for
preventing
RID
associated
symptoms
in
patients
with
cancer.
Cancer
were
randomly
assigned
1:1
open-label
randomized
clinical
trial.
Patients
prophylactic
group
received
preventative
treatment
(one
day
before
radiotherapy).
interventional
(upon
development
grade
2
RID).
Outcome
measures
scored
according
to
Radiation
Therapy
Oncology
Group
European
Organization
Research
Treatment
Cancer.
Patient-reported
skin
(Skindex-16),
quality
life
(QLQ-C30),
adverse
effects
(CTCAE
V4.0)
investigated.
Among
71
participants,
showed
significant
relief
a
medium
size
itching,
hurting,
burning
or
stinging
(p
<
.05,
>0.5)
compared
group.
No
statistically
difference
incidence
was
found
(51%
vs.
53%
group,
p
=
.91).
The
application
did
not
affect
patient
life.
reactions
observed.
Preventative
can
alleviate
radiation
dermatitis-related
good
safety,
which
indicates
that
could
be
option
integration
care
improve
RT
breast,
lung,
head
neck
cancers.
Language: Английский
Radiation‐Resistant Bacteria Deinococcus radiodurans‐Derived Extracellular Vesicles as Potential Radioprotectors
Advanced Healthcare Materials,
Journal Year:
2024,
Volume and Issue:
unknown
Published: Dec. 15, 2024
The
increasing
use
of
radiation
presents
a
risk
exposure,
making
the
development
radioprotectors
necessary.
In
previous
study,
it
is
investigated
that
Deinococcus
radiodurans
(R1-EVs)
exert
antioxidative
properties.
However,
radioprotective
activity
R1-EVs
remains
unclear.
present
protective
effects
against
total
body
irradiation
(TBI)-induced
acute
syndrome
(ARS)
are
investigated.
To
assess
R1-EVs'
efficacy,
ARS
induced
in
mice
with
8
Gy
TBI,
and
protection
hematopoietic
(H)-
gastrointestinal
(GI)-ARS
evaluated.
survival
rate
irradiated
group
decreases
substantially
after
irradiation.
contrast,
pretreatment
increases
rates
mice.
administration
provides
effective
radiation-induced
death
bone
marrow
cells
splenocytes
by
scavenging
reactive
oxygen
species
(ROS).
Additionally,
protect
both
intestinal
stem
epithelial
from
apoptosis.
stimulate
production
short-chain
fatty
acids
tract,
suppress
proinflammatory
cytokines,
increase
regulatory
T
pretreated
versus
irradiation-only
group.
Proteomic
analysis
shows
R1-EV
proteome
significantly
enriched
proteins
involved
oxidative
stress
response.
These
findings
highlight
as
potent
applications
damage
ROS-mediated
diseases.
Language: Английский